Defective antigen-presenting cell function in human neonates
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Immaturity of the immune system has been suggested as an underlying factor for the high rate of morbidity and mortality from infections in newborns. Functional impairment of neonatal T cells is frequently quoted as the main underlying mechanism for such immaturity. However, recent studies suggest that neonatal antigen-presenting cells (APCs) also exhibit functional alterations, which could lead to secondary defects of adaptive T-cell responses. In this review, we summarize what is known on the functionality of APC at birth and during early childhood. Compared to adults, neonatal APCs display markers of immaturity and produce low levels of cytokines. Multiple factors could be involved in neonatal APC alteration, such as intrinsic immaturity, defective interaction between APCs and T cells and regulatory T-cell-mediated inhibition. Characterization of the relative contribution of each mechanism is clearly needed to better understand the functional capability of the neonatal immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“Interestingly, FOXP3 has been shown to upregulate both CTLA-4 and CD25 genes [67], which could explain why ectopic expression of FOXP3 transforms non-Treg into functional inhibitory Treg [68].”
BackgroundToll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193 · cited 1×
“However, it is important to underline that the response to other TLRs expressed in this cellular population, TLR1, 2, 3, 6, and 8 and possibly TLR5 [33], has not yet been reported in neonate cells.”
BackgroundPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585 · cited 1×
“They may be crucial in the high IDO level detected at the fetal-maternal interface, which has been proposed as a major factor in the lower immune reactivity of this compartment [71-75].”
BackgroundA conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342 · cited 1×
“Since it has been shown in murine models that viral infection of DCs can override the need for CD4+ T cell costimulation to induce CD8+ responses [53], a similar mechanism could be at play for in utero infection by HIV and CMV.”
BackgroundCella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., & Alber, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.747 · Cited by 1,983 · cited 1×
“Since optimal activation of APCs involves crosstalk with activated CD4+ T cells [54,55], defective neonatal T cell activation will induce defective function of neonatal APCs.”
BackgroundNakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,594 · cited 1×
“There is also evidence supporting the effect of membrane-associated TGF-β as a mechanism underlying nTreg activity [66].”
BackgroundModulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M.-L., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,374 · cited 1×
“An interesting piece of evidence is the nTreg -induced up-regulation of the tryptophancatabolizing enzyme indoleamine 2,3-dioxigenase (IDO) in APCs, mainly DCs [62,63].”
BackgroundImmature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?
Lutz, M. B., & Schuler, G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02281-0 · Cited by 1,349 · cited 1×
“Both quantitative and qualitative alterations in such interactions promote the development of tolerance in effector T cells [11-14].”
BackgroundItoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5317 · Cited by 1,211 · cited 1×
“Natural regulatory T cells (nTreg) have a thymic origin [61] and have proved essential in the establishment and maintenance of immunological tolerance [58].”
BackgroundFOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189 · cited 1×
“Interestingly, FOXP3 has been shown to upregulate both CTLA-4 and CD25 genes [67], which could explain why ectopic expression of FOXP3 transforms non-Treg into functional inhibitory Treg [68].”
Background
Cited by
Perez-Muñoz, M. E., Arrieta, M.-C., Ramer-Tait, A. E., & Walter, J. (2017) · Microbiome · doi:10.1186/s40168-017-0268-4 · Cited by 1,096
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Hu, Y., Hu, Q., Li, Y., Lu, L., Xiang, Z., Yin, Z., Kabelitz, D., & Wu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01653-8 · Cited by 382
Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes
the BABYDIAB-BABYDIET Study Group, Ziegler, A.-G., & Bonifacio, E. (2012) · Diabetologia · doi:10.1007/s00125-012-2472-x · Cited by 264
Microbes, immunity, and behavior: psychoneuroimmunology meets the microbiome
Dinan, T. G., & Cryan, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.103 · Cited by 246
Gut Microbiota: The Conductor in the Orchestra of Immune–Neuroendocrine Communication
El Aidy, S., Dinan, T. G., & Cryan, J. F. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.03.002 · Cited by 215
“Neonates have a decreased expression of costimulatory molecules, diminished dendritic cell (DC) differentiation, and impaired phagocytosis as well as a defective interaction between DCs, T lymphocytes, and regulatory T cells, impaired cytotoxic activity of T cells.(31,32) Moreover, the suppressive activity of the tran…”
BackgroundPostnatal Innate Immune Development: From Birth to Adulthood
Georgountzou, A., & Papadopoulos, N. G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00957 · Cited by 204
“Neonatal monocytes have been reported to display impaired chemotactic activity and altered phagocytosis (112, 137).”
BackgroundEFSA Scientific Committee, Hardy, A., Benford, D., Halldorsson, T., Jeger, M. J., Knutsen, H. K., More, S., Naegeli, H., Noteborn, H., Ockleford, C., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4849 · Cited by 202
“…in the neonate and the young infant (Gasparoni et al., 2003; Kotiranta-Ainamo et al., 2004; Hartel et al., 2005; Dietert and Piepenbrink, 2006; Velilla et al., 2006; Adkins, 2007; Morein Risk assessment of substances in food for infants www.efsa.europa.eu/efsajournal 30 EFSA Journal…”
BackgroundRole of Innate Host Defenses in Susceptibility to Early-Onset Neonatal Sepsis
Wynn, J. L., & Levy, O. (2010) · Clinics in Perinatology · doi:10.1016/j.clp.2010.04.001 · Cited by 185
Metadata
- Authors
- Velilla, P. A., Rugeles, M. T., & Chougnet, C. A.
- Venue
- Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 121
- Issue
- 3
- Pages
- 251-259
- ISSN
- 1521-6616 (ISSN-L)
- OpenAlex
- W2052012061
- Cited by
- 175
- References
- 76
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.